This brand name is authorized in Austria, Australia, Canada, Estonia, Hong Kong, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, United Kingdom, United States
The drug ZEPOSIA contains one active pharmaceutical ingredient (API):
|
1
Ozanimod
UNII 3UPR33JAAM - OZANIMOD HYDROCHLORIDE
|
|
Ozanimod is a sphingosine 1-phosphate (S1P) receptor modulator, which binds selectively to sphingosine 1-phosphate receptor subtypes 1 and 5. Ozanimod causes lymphocyte retention in lymphoid tissues. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| ZEPOSIA Hard capsule | European Medicines Agency (EU) | MPI, EU: SmPC | |
| ZEPOSIA Capsule | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L04AE02 | L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AE Sphingosine-1-phosphate (S1P) receptor modulators | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 12271W, 12278F |
| Country: CA | Health Products and Food Branch | Identifier(s): 02505991, 02506009 |
| Country: EE | Ravimiamet | Identifier(s): 1820854, 1820876, 1820966 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 391303, 391306, 391309, 391312 |
| Country: HK | Department of Health Drug Office | Identifier(s): 67126, 67127 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 89088, 89089 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 8798, 8799, 8800 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1090323, 1090324, 1090325 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 203939, 203947 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 22323, 22324 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100438934, 100438940 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W67064001, W67065001, W67065002 |
| Country: US | FDA, National Drug Code | Identifier(s): 59572-820 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
